TY - JOUR
T1 - Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response
AU - Zhou, Gang
AU - Ding, Zhi Chun
AU - Fu, Jie
AU - Levitsky, Hyam I.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2011/2/15
Y1 - 2011/2/15
N2 - Activated T cells can acquire membrane molecules from APCs through a process termed trogocytosis. The functional consequence of this event has been a subject of debate. Focusing on transfer of peptide-MHC class II (MHC-II) complexes from APCs to CD4+ T cells after activation, in this study we investigated the molecule acquisition potential of naturally occurring regulatory T cells (Tregs) and CD4+ Th cells. We show that acquisition of membrane molecules from APCs is an inherent feature of CD4 + T cell activation. Triggering of the TCR enables CD4+ T cells to acquire their agonist ligands as well as other irrelevant membrane molecules from the interacting APCs or bystander cells in a contact-dependent manner. Notably, trogocytosis is a continuous process during cell cycle progression, and Th cells and Tregs have comparable capacity for trogocytosis both in vitro and in vivo. The captured peptide-MHC-II molecules, residing in sequestered foci on the host cell surface, endow the host cells with Ag-presenting capability. Presentation of acquired peptide-MHC-II ligands by Th cells or Tregs has either stimulatory or regulatory effect on naive CD4 + T cells, respectively. Furthermore, Th cells with captured peptide-MHC-II molecules become effector cells that manifest better recall responses, and Tregs with captured ligands exhibit enhanced suppression activity. These findings implicate trogocytosis in different subsets of CD4 + T cells as an intrinsic mechanism for the fine tuning of Ag-specific CD4+ T cell response.
AB - Activated T cells can acquire membrane molecules from APCs through a process termed trogocytosis. The functional consequence of this event has been a subject of debate. Focusing on transfer of peptide-MHC class II (MHC-II) complexes from APCs to CD4+ T cells after activation, in this study we investigated the molecule acquisition potential of naturally occurring regulatory T cells (Tregs) and CD4+ Th cells. We show that acquisition of membrane molecules from APCs is an inherent feature of CD4 + T cell activation. Triggering of the TCR enables CD4+ T cells to acquire their agonist ligands as well as other irrelevant membrane molecules from the interacting APCs or bystander cells in a contact-dependent manner. Notably, trogocytosis is a continuous process during cell cycle progression, and Th cells and Tregs have comparable capacity for trogocytosis both in vitro and in vivo. The captured peptide-MHC-II molecules, residing in sequestered foci on the host cell surface, endow the host cells with Ag-presenting capability. Presentation of acquired peptide-MHC-II ligands by Th cells or Tregs has either stimulatory or regulatory effect on naive CD4 + T cells, respectively. Furthermore, Th cells with captured peptide-MHC-II molecules become effector cells that manifest better recall responses, and Tregs with captured ligands exhibit enhanced suppression activity. These findings implicate trogocytosis in different subsets of CD4 + T cells as an intrinsic mechanism for the fine tuning of Ag-specific CD4+ T cell response.
UR - http://www.scopus.com/inward/record.url?scp=79951823669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951823669&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1002917
DO - 10.4049/jimmunol.1002917
M3 - Article
C2 - 21242518
AN - SCOPUS:79951823669
SN - 0022-1767
VL - 186
SP - 2148
EP - 2155
JO - Journal of Immunology
JF - Journal of Immunology
IS - 4
ER -